Gene profiling of immune responses against tumors

Ena Wang, Monica C. Panelli, Francesco M. Marincola

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Clinical trials of tumor-antigen-specific immunization have clearly shown that immune-mediated tumor rejection requires more than simple T cell-target cell interactions. In vivo generation of tumor-specific T cells is one of a series of steps necessary for the induction of clinically relevant immune responses. In recent years, high-throughput functional genomics exposed the complexity of tumor immune biology, which underlies the kaleidoscopic array of variables associated with cancer instability and immunogenetic variability in humans. In the quest to understand immune rejection, hypothesis-driven approaches have failed to take into account the intricacy of human pathology by relying mostly on hypotheses derived from experimental models rather than direct clinical observation. Future investigations should reframe scientific thinking when applied to humans, utilizing descriptive tools to generate novel hypotheses relevant to human disease.

Original languageEnglish
Pages (from-to)423-427
Number of pages5
JournalCurrent Opinion in Immunology
Volume17
Issue number4 SPEC. ISS.
DOIs
Publication statusPublished - Aug 2005
Externally publishedYes

Fingerprint

Genes
Neoplasms
T-Lymphocytes
Immunogenetics
Neoplasm Antigens
Genomics
Cell Communication
Immunization
Theoretical Models
Observation
Clinical Trials
Pathology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Gene profiling of immune responses against tumors. / Wang, Ena; Panelli, Monica C.; Marincola, Francesco M.

In: Current Opinion in Immunology, Vol. 17, No. 4 SPEC. ISS., 08.2005, p. 423-427.

Research output: Contribution to journalReview article

Wang, Ena ; Panelli, Monica C. ; Marincola, Francesco M. / Gene profiling of immune responses against tumors. In: Current Opinion in Immunology. 2005 ; Vol. 17, No. 4 SPEC. ISS. pp. 423-427.
@article{f626647daff544b3a295b2a7aa01eec6,
title = "Gene profiling of immune responses against tumors",
abstract = "Clinical trials of tumor-antigen-specific immunization have clearly shown that immune-mediated tumor rejection requires more than simple T cell-target cell interactions. In vivo generation of tumor-specific T cells is one of a series of steps necessary for the induction of clinically relevant immune responses. In recent years, high-throughput functional genomics exposed the complexity of tumor immune biology, which underlies the kaleidoscopic array of variables associated with cancer instability and immunogenetic variability in humans. In the quest to understand immune rejection, hypothesis-driven approaches have failed to take into account the intricacy of human pathology by relying mostly on hypotheses derived from experimental models rather than direct clinical observation. Future investigations should reframe scientific thinking when applied to humans, utilizing descriptive tools to generate novel hypotheses relevant to human disease.",
author = "Ena Wang and Panelli, {Monica C.} and Marincola, {Francesco M.}",
year = "2005",
month = "8",
doi = "10.1016/j.coi.2005.05.007",
language = "English",
volume = "17",
pages = "423--427",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",
number = "4 SPEC. ISS.",

}

TY - JOUR

T1 - Gene profiling of immune responses against tumors

AU - Wang, Ena

AU - Panelli, Monica C.

AU - Marincola, Francesco M.

PY - 2005/8

Y1 - 2005/8

N2 - Clinical trials of tumor-antigen-specific immunization have clearly shown that immune-mediated tumor rejection requires more than simple T cell-target cell interactions. In vivo generation of tumor-specific T cells is one of a series of steps necessary for the induction of clinically relevant immune responses. In recent years, high-throughput functional genomics exposed the complexity of tumor immune biology, which underlies the kaleidoscopic array of variables associated with cancer instability and immunogenetic variability in humans. In the quest to understand immune rejection, hypothesis-driven approaches have failed to take into account the intricacy of human pathology by relying mostly on hypotheses derived from experimental models rather than direct clinical observation. Future investigations should reframe scientific thinking when applied to humans, utilizing descriptive tools to generate novel hypotheses relevant to human disease.

AB - Clinical trials of tumor-antigen-specific immunization have clearly shown that immune-mediated tumor rejection requires more than simple T cell-target cell interactions. In vivo generation of tumor-specific T cells is one of a series of steps necessary for the induction of clinically relevant immune responses. In recent years, high-throughput functional genomics exposed the complexity of tumor immune biology, which underlies the kaleidoscopic array of variables associated with cancer instability and immunogenetic variability in humans. In the quest to understand immune rejection, hypothesis-driven approaches have failed to take into account the intricacy of human pathology by relying mostly on hypotheses derived from experimental models rather than direct clinical observation. Future investigations should reframe scientific thinking when applied to humans, utilizing descriptive tools to generate novel hypotheses relevant to human disease.

UR - http://www.scopus.com/inward/record.url?scp=20544442173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544442173&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2005.05.007

DO - 10.1016/j.coi.2005.05.007

M3 - Review article

VL - 17

SP - 423

EP - 427

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

IS - 4 SPEC. ISS.

ER -